Y. Shirai

发表

Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats

H. Yoshiji, T. Tsujimoto, H. Fukui, 2010, Journal of Gastroenterology.

Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.

H. Yoshiji, H. Fukui, R. Noguchi, 2011, International journal of molecular medicine.

Selective aldosterone blocker, eplerenone, attenuates hepatocellular carcinoma growth and angiogenesis in mice

H. Yoshiji, T. Tsujimoto, M. Yamazaki, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Cross talk between toll‐like receptor‐4 signaling and angiotensin‐II in liver fibrosis development in the rat model of non‐alcoholic steatohepatitis

H. Yoshiji, H. Fukui, R. Noguchi, 2013, Journal of gastroenterology and hepatology.

Direct renin inhibitor, aliskiren, attenuates the progression of non‐alcoholic steatohepatitis in the rat model

H. Yoshiji, H. Fukui, R. Noguchi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

A Case of Lobulated and Pedunculated Duodenal Hyperplastic Polyp Treated with Snare Polypectomy

T. Tsujimoto, H. Fukui, Y. Shirai, 2011, Case Reports in Gastroenterology.

Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.

H. Yoshiji, T. Tsujimoto, H. Fukui, 2011, American journal of physiology. Gastrointestinal and liver physiology.

A histologically proven case of progressive liver sarcoidosis with variceal rupture.

H. Yoshiji, H. Fukui, M. Uemura, 2011, World journal of hepatology.

Large cell neuroendocrine carcinoma presenting with neck swelling in the submandibular gland: a case report

H. Yoshiji, T. Tsujimoto, H. Fukui, 2013, Journal of Medical Case Reports.

Dual blockade of angiotensin‐II and aldosterone suppresses the progression of a non‐diabetic rat model of steatohepatitis

H. Yoshiji, H. Fukui, R. Noguchi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

H. Yoshiji, H. Fukui, R. Noguchi, 2014, Journal of Gastroenterology.

Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats.

H. Yoshiji, T. Tsujimoto, M. Yamazaki, 2010, International journal of molecular medicine.

Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents.

H. Yoshiji, T. Tsujimoto, A. Mitoro, 2011, Oncology letters.

The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure

H. Yoshiji, T. Tsujimoto, H. Fukui, 2010, Journal of angiogenesis research.

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis.

H. Yoshiji, T. Tsujimoto, A. Mitoro, 2009, World Journal of Gastroenterology.

Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report

H. Yoshiji, Y. Nakajima, A. Mitoro, 2011, Journal of medical case reports.

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat

H. Yoshiji, T. Tsujimoto, M. Yamazaki, 2009, BMC Research Notes.